Ego inflation

Ego inflation is an unwarranted sense of superiority, grandiosity, or exceptional significance that arises acutely under psychoactive substances.

As a drug effect it is dose-proportional and eases as the substance wears off, setting it apart from any standing personality trait. It ranges from mild overconfidence to a full conviction of invulnerability or special status, and can prompt poor decisions while it persists.

It is an uncommon effect reported across several substance classes. It is most commonly induced at moderate to high doses under stimulants such as amphetamine, MDMA, and cocaine, and under psychedelics such as psilocybin mushrooms and DMT. It also appears under dissociatives like ketamine and dextromethorphan, and under depressants such as alcohol.

Ego inflation is felt as a quiet but insistent conviction that one is more capable, more significant, or more perceptive than others: judgment feels sharper, social hesitation dissolves, and criticism registers as evidence of others' limitations rather than one's own.

It commonly comes with heightened energy and an expansive ease in social situations, alongside a reduced appetite for caution. The appraisal tends to feel self-evident from within, making it self-reinforcing. At higher doses, particularly under stimulants and psychedelics, it can harden into a certainty resistant to outside challenge.

Ego inflation arises through different pathways depending on the drug class:

• Stimulants — elevate dopamine in reward circuits, producing a heightened sense of competence and drive that can tip into grandiosity.
• Psychedelics — act on 5-HT2A receptors, loosening self-critical constraints and allowing an inflated sense of personal significance to emerge.
• Depressants — suppress prefrontal self-monitoring through GABAergic disinhibition, lowering the restraints that ordinarily temper self-appraisal.
• Dissociatives — block NMDA receptors, detaching self-perception from external feedback and allowing grandiose appraisals to persist unchallenged.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses raise both likelihood and intensity. Set and setting are significant — social environments that confer status or admiration, especially under stimulants, increase the risk.

People with a pre-existing tendency toward confident self-appraisal are more susceptible, as are those with prior episodes of inflation. Expectation shapes the effect: entering an experience already feeling superior tends to reinforce it. A grounding setting and trusted company reduce it.